Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2005 Sep;81(959):604–607. doi: 10.1136/pgmj.2004.030544

Potential role of interleukin 6 in reactive thrombocytosis and acute phase response in pulmonary tuberculosis

E Unsal 1, S Aksaray 1, D Koksal 1, T Sipit 1
PMCID: PMC1743352  PMID: 16143693

Abstract

Objective: Reactive thrombocytosis is found in a number of clinical situations including infectious diseases such as pulmonary tuberculosis (PTB). To examine the possible role of interleukin (IL6) in reactive thrombocytosis and acute phase response in PTB this study measured serum IL6, C reactive protein (CRP), erythrocyte sedimentation rate (ESR), albumin concentrations in 62 PTB patients and 20 healthy volunteers.

Method: PTB patients were divided into two groups based on thrombocyte counts. Twenty seven PTB patients with normal thrombocyte counts constituted group 1, 35 PTB patients with thrombocytosis constituted group 2, and 20 healthy volunteers constituted group 3.

Results: The median IL6 concentration of group 1 was 12.8 pg/ml (95% CI: 12.1 to 56.9 pg/ml) and group 2 was 40.6 pg/ml (95% CI: 67.1 to 168.7 pg/ml). The comparison of IL6 concentrations in the three groups was significant (p = 0.0001). Patients in group 1 had a higher concentration of CRP (p = 0.0001) and lower concentration of albumin (p = 0.002) than group 3 whereas group 2 had higher concentration of CRP (p = 0.003) and lower concentration of albumin (p = 0.002) than group 1. Serum IL6 concentrations were significantly correlated with thrombocyte counts (p = 0.004, r = 0.36), CRP (p = 0.007, r = 0.34), and albumin concentrations (p = 0.005, r = –0.34). IL6 concentrations were significantly correlated with the number of involved zones (p = 0.005, r = 0.35) and acid fast bacilli positivity (p = 0.03, r = 0.27). Patients in group 2 had weight loss (p = 0.004), fever (p = 0.038), and night sweats (p = 0.007) more frequently than group 1. Also, group 2 had more extensive radiological findings (involved zones p = 0.001, bilateral disease p = 0.0001, presence of cavity p = 0.02) than group 1.

Conclusions: IL6 might play a contributory part in reactive thrombocytosis and acute phase response in PTB.

Full Text

The Full Text of this article is available as a PDF (74.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauer J., Herrmann F. Interleukin-6 in clinical medicine. Ann Hematol. 1991 Jun;62(6):203–210. doi: 10.1007/BF01729833. [DOI] [PubMed] [Google Scholar]
  2. Baynes R. D., Bothwell T. H., Flax H., McDonald T. P., Atkinson P., Chetty N., Bezwoda W. R., Mendelow B. V. Reactive thrombocytosis in pulmonary tuberculosis. J Clin Pathol. 1987 Jun;40(6):676–679. doi: 10.1136/jcp.40.6.676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Evans C. A., Jellis J., Hughes S. P., Remick D. G., Friedland J. S. Tumor necrosis factor-alpha, interleukin-6, and interleukin-8 secretion and the acute-phase response in patients with bacterial and tuberculous osteomyelitis. J Infect Dis. 1998 Jun;177(6):1582–1587. doi: 10.1086/515313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Haznedaroğlu I. C., Ertenli I., Ozcebe O. I., Kiraz S., Ozdemir O., Sayinalp N. M., Dündar S. V., Calgüneri M., Kirazli S. Megakaryocyte-related interleukins in reactive thrombocytosis versus autonomous thrombocythemia. Acta Haematol. 1996;95(2):107–111. doi: 10.1159/000203857. [DOI] [PubMed] [Google Scholar]
  5. Hill R. J., Warren M. K., Levin J. Stimulation of thrombopoiesis in mice by human recombinant interleukin 6. J Clin Invest. 1990 Apr;85(4):1242–1247. doi: 10.1172/JCI114559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hoheisel G., Izbicki G., Roth M., Chan C. H., Leung J. C., Reichenberger F., Schauer J., Perruchoud A. P. Compartmentalization of pro-inflammatory cytokines in tuberculous pleurisy. Respir Med. 1998 Jan;92(1):14–17. doi: 10.1016/s0954-6111(98)90025-7. [DOI] [PubMed] [Google Scholar]
  7. Hollen C. W., Henthorn J., Koziol J. A., Burstein S. A. Elevated serum interleukin-6 levels in patients with reactive thrombocytosis. Br J Haematol. 1991 Oct;79(2):286–290. doi: 10.1111/j.1365-2141.1991.tb04534.x. [DOI] [PubMed] [Google Scholar]
  8. Kaser A., Brandacher G., Steurer W., Kaser S., Offner F. A., Zoller H., Theurl I., Widder W., Molnar C., Ludwiczek O. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood. 2001 Nov 1;98(9):2720–2725. doi: 10.1182/blood.v98.9.2720. [DOI] [PubMed] [Google Scholar]
  9. Kimura H., Ishibashi T., Uchida T., Maruyama Y., Friese P., Burstein S. A. Interleukin 6 is a differentiation factor for human megakaryocytes in vitro. Eur J Immunol. 1990 Sep;20(9):1927–1931. doi: 10.1002/eji.1830200909. [DOI] [PubMed] [Google Scholar]
  10. Kishimoto T. The biology of interleukin-6. Blood. 1989 Jul;74(1):1–10. [PubMed] [Google Scholar]
  11. Klein B., Wijdenes J., Zhang X. G., Jourdan M., Boiron J. M., Brochier J., Liautard J., Merlin M., Clement C., Morel-Fournier B. Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood. 1991 Sep 1;78(5):1198–1204. [PubMed] [Google Scholar]
  12. Law K., Weiden M., Harkin T., Tchou-Wong K., Chi C., Rom W. N. Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. Am J Respir Crit Care Med. 1996 Feb;153(2):799–804. doi: 10.1164/ajrccm.153.2.8564135. [DOI] [PubMed] [Google Scholar]
  13. Mayer P., Geissler K., Valent P., Ceska M., Bettelheim P., Liehl E. Recombinant human interleukin 6 is a potent inducer of the acute phase response and elevates the blood platelets in nonhuman primates. Exp Hematol. 1991 Aug;19(7):688–696. [PubMed] [Google Scholar]
  14. Nakano T., Chahinian A. P., Shinjo M., Tonomura A., Miyake M., Togawa N., Ninomiya K., Higashino K. Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma. Br J Cancer. 1998 Mar;77(6):907–912. doi: 10.1038/bjc.1998.150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nijsten M. W., de Groot E. R., ten Duis H. J., Klasen H. J., Hack C. E., Aarden L. A. Serum levels of interleukin-6 and acute phase responses. Lancet. 1987 Oct 17;2(8564):921–921. doi: 10.1016/s0140-6736(87)91413-9. [DOI] [PubMed] [Google Scholar]
  16. Ogawa T., Uchida H., Kusumoto Y., Mori Y., Yamamura Y., Hamada S. Increase in tumor necrosis factor alpha- and interleukin-6-secreting cells in peripheral blood mononuclear cells from subjects infected with Mycobacterium tuberculosis. Infect Immun. 1991 Sep;59(9):3021–3025. doi: 10.1128/iai.59.9.3021-3025.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Orme I. M., Andersen P., Boom W. H. T cell response to Mycobacterium tuberculosis. J Infect Dis. 1993 Jun;167(6):1481–1497. doi: 10.1093/infdis/167.6.1481. [DOI] [PubMed] [Google Scholar]
  18. Poveda F., Camacho J., Arnalich F., Codoceo R., del Arco A., Martínez-Hernández P. Circulating cytokine concentrations in tuberculosis and other chronic bacterial infections. Infection. 1999;27(4-5):272–274. doi: 10.1007/s150100050028. [DOI] [PubMed] [Google Scholar]
  19. Robson S. C., White N. W., Aronson I., Woollgar R., Goodman H., Jacobs P. Acute-phase response and the hypercoagulable state in pulmonary tuberculosis. Br J Haematol. 1996 Jun;93(4):943–949. doi: 10.1046/j.1365-2141.1996.d01-1722.x. [DOI] [PubMed] [Google Scholar]
  20. Tefferi A., Ho T. C., Ahmann G. J., Katzmann J. A., Greipp P. R. Plasma interleukin-6 and C-reactive protein levels in reactive versus clonal thrombocytosis. Am J Med. 1994 Oct;97(4):374–378. doi: 10.1016/0002-9343(94)90306-9. [DOI] [PubMed] [Google Scholar]
  21. Tsao T. C., Hong J., Huang C., Yang P., Liao S. K., Chang K. S. Increased TNF-alpha, IL-1 beta and IL-6 levels in the bronchoalveolar lavage fluid with the upregulation of their mRNA in macrophages lavaged from patients with active pulmonary tuberculosis. Tuber Lung Dis. 1999;79(5):279–285. doi: 10.1054/tuld.1999.0215. [DOI] [PubMed] [Google Scholar]
  22. Turken O., Kunter E., Sezer M., Solmazgul E., Cerrahoglu K., Bozkanat E., Ozturk A., Ilvan A. Hemostatic changes in active pulmonary tuberculosis. Int J Tuberc Lung Dis. 2002 Oct;6(10):927–932. [PubMed] [Google Scholar]
  23. Yokoyama A., Maruyama M., Ito M., Kohno N., Hiwada K., Yano S. Interleukin 6 activity in pleural effusion. Its diagnostic value and thrombopoietic activity. Chest. 1992 Oct;102(4):1055–1059. doi: 10.1378/chest.102.4.1055. [DOI] [PubMed] [Google Scholar]
  24. el-Ahmady O., Mansour M., Zoeir H., Mansour O. Elevated concentrations of interleukins and leukotriene in response to Mycobacterium tuberculosis infection. Ann Clin Biochem. 1997 Mar;34(Pt 2):160–164. doi: 10.1177/000456329703400205. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES